Pediatric and Caregiver Traumatic Stress Intervention (PACTS)
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Apr 10, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Pediatric and Caregiver Traumatic Stress Intervention (PACTS) trial is a study designed to help children and their caregivers cope with the emotional effects of traumatic injuries, such as those from accidents or burns. The goal is to learn how to better support families dealing with post-traumatic stress disorder (PTSD) and depression after these events. If you have a child who has been hospitalized for an unintentional injury, and you both are facing stress or emotional difficulties, you may be invited to join this study.
To participate, you need to be an English-speaking caregiver of a child aged 1 to 6 years who is receiving treatment for an injury. Both you and your child will be part of a process where you can receive support and counseling. However, if there are significant cognitive issues or severe mental health symptoms, or if you choose not to participate, you would not be eligible for this study. This trial is currently looking for participants, and joining could provide valuable tools to help you and your child manage the aftermath of a traumatic experience together.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Child requires inpatient treatment for an unintentional injury (e.g. burns, dog bite, road traffic accident) in the pediatric trauma and/or pediatric burns units
- • English-speaking adults, with English denoted as the primary language in the electronic medical record (EMR)
- • Caregiver-child dyads who screen positive with the Peritraumatic Distress Inventory (PDI) Tools will be invited to participate in the randomized controlled trial.
- Exclusion Criteria:
- • Patients and/or caregivers with cognitive deficits, with psychotic symptoms, refusing treatment, and leaving the hospital against medical advice (AMA) were unable to participate in counseling interventions by condition or by choice and are excluded from the study population
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Elizabeth Shilling, PhD
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported